Cytokinetics (CYTK) Change in Accured Expenses (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Change in Accured Expenses of -$6.2 million for Q1 2026, up 56.76% year-over-year from -$4.0 million in Q1 2025, and down 123.56% quarter-over-quarter from $26.4 million in Q4 2025.
Cytokinetics (CYTK) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Change in Accured Expenses for 17 consecutive years, with -$6.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 56.76% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at $41.8 million (up 674.14% YoY), while the FY2025 annual figure was $33.6 million, up 136.94% from the prior year.
- Change in Accured Expenses declined to -$6.2 million in Q1 2026 per CYTK's latest filing, from $26.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $32.1 million in Q4 2023 and bottomed at -$14.4 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $4.1 million across 5 years, with a median of $4.2 million in 2024.
- On a YoY basis, Change in Accured Expenses climbed as much as 9253.56% in 2023 and fell as far as 287.96% in 2023.
- Cytokinetics' Change in Accured Expenses stood at -$351000.0 in 2022, then surged by 9253.56% to $32.1 million in 2023, then sank by 68.64% to $10.1 million in 2024, then soared by 161.67% to $26.4 million in 2025, then slumped by 123.56% to -$6.2 million in 2026.
- Business Quant data shows CYTK's Change in Accured Expenses at -$6.2 million in Q1 2026, $26.4 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.25 Mn |
| Jun 30, 2026 | 5.25 Mn |
| Mar 31, 2026 | -6.21 Mn |
| Mar 31, 2026 | -6.21 Mn |
| Dec 31, 2025 | 26.37 Mn |
| Dec 31, 2025 | 26.37 Mn |
| Sep 30, 2025 | 7.62 Mn |
| Sep 30, 2025 | 7.62 Mn |
| Jun 30, 2025 | 13.99 Mn |
| Jun 30, 2025 | 13.99 Mn |
| Mar 31, 2025 | -14.37 Mn |
| Mar 31, 2025 | -14.37 Mn |
| Dec 31, 2024 | 10.08 Mn |
| Dec 31, 2024 | 10.08 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | -5.58 Mn |
| Mar 31, 2024 | -5.58 Mn |